Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Martinez Høyer

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Experimental Hematology|September 25, 2020
Mechanisms of lenalidomide sensitivity and resistanceSergio Martinez-Høyer, Aly Karsan
Nature Communications|June 22, 2018
miR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signalingJeffrey Lam, Marion van den Bosch, Joanna Wegrzyn, et al.
Nature Cell Biology|April 7, 2020
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndromeSergio Martinez-Høyer, Yu Deng, Jeremy Parker, et al.
The Journal of Experimental Medicine|June 18, 2024
Human CD127 negative ILC2s show immunological memoryLaura Mathä, Lisette Krabbendam, Sergio Martinez Høyer, et al.
Nature Communications|May 1, 2021
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemiaT Roderick Docking, Jeremy D K Parker, Martin Jädersten, et al.
Blood Advances|January 11, 2022
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansionUrsula S A Stalmann, Fabio Ticconi, Inge A M Snoeren, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Experimental Hematology|September 25, 2020
Mechanisms of lenalidomide sensitivity and resistanceSergio Martinez-Høyer, Aly Karsan
Nature Communications|June 22, 2018
miR-143/145 differentially regulate hematopoietic stem and progenitor activity through suppression of canonical TGFβ signalingJeffrey Lam, Marion van den Bosch, Joanna Wegrzyn, et al.
Nature Cell Biology|April 7, 2020
Loss of lenalidomide-induced megakaryocytic differentiation leads to therapy resistance in del(5q) myelodysplastic syndromeSergio Martinez-Høyer, Yu Deng, Jeremy Parker, et al.
The Journal of Experimental Medicine|June 18, 2024
Human CD127 negative ILC2s show immunological memoryLaura Mathä, Lisette Krabbendam, Sergio Martinez Høyer, et al.
Nature Communications|May 1, 2021
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemiaT Roderick Docking, Jeremy D K Parker, Martin Jädersten, et al.
Blood Advances|January 11, 2022
Genetic barcoding systematically compares genes in del(5q) MDS and reveals a central role for CSNK1A1 in clonal expansionUrsula S A Stalmann, Fabio Ticconi, Inge A M Snoeren, et al.
Pageof 1